Detalhe da pesquisa
1.
Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids.
PLoS Pathog
; 19(8): e1011559, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619220
2.
Mycobacteria-host interactions in human bronchiolar airway organoids.
Mol Microbiol
; 117(3): 682-692, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605588
3.
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis.
Clin Infect Dis
; 75(12): 2135-2144, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35475917
4.
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Eur Respir J
; 59(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764182
5.
Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Eur Respir J
; 2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795038
6.
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.
Am J Respir Crit Care Med
; 201(2): 188-197, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601120
7.
Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.
BMC Pulm Med
; 20(1): 159, 2020 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503487
8.
Use of Ultrasonography for Lung Transplant Recipients on Postoperative Care.
J Ultrasound Med
; 38(4): 1101-1108, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121959
9.
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Ann Am Thorac Soc
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579175
10.
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
Chest
; 165(6): 1307-1318, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387646
11.
Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study.
BMJ Open Respir Res
; 10(1)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524523
12.
Bronchiectasis and inhaled tobramycin: A literature review.
Respir Med
; 192: 106728, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998112
13.
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.
J Cyst Fibros
; 21(3): 489-496, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123901
14.
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.
J Cyst Fibros
; 21(3): 529-536, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961705
15.
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.
J Cyst Fibros
; 20(2): 220-227, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591294
16.
Practice of noninvasive ventilation for cystic fibrosis: a nationwide survey in France.
Respir Care
; 53(11): 1482-9, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957151
17.
Numerical and experimental investigation of mucociliary clearance breakdown in cystic fibrosis.
J Biomech
; 53: 56-63, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28117099
18.
Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Pediatr Pulmonol
; 52(2): 190-197, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717223
19.
Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices.
Respir Med Res
; 80: 100859, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563790
20.
The EMBARC European Bronchiectasis Registry: protocol for an international observational study.
ERJ Open Res
; 2(1)2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27730179